MBX Biosciences (MBX) Shares Outstanding (Weighted Average) (2023 - 2026)

MBX Biosciences has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $46.6 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $46.6 million, up 39.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.6 million (up 39.4% YoY), and the FY2025 annual result was $36.5 million, up 243.01% from the prior year.
• Shares Outstanding (Weighted Average) came in at $46.6 million for Q1 2026 at MBX Biosciences, up from $36.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.6 million in Q1 2026 to a low of $1.0 million in Q4 2023.
• The 4-year median for Shares Outstanding (Weighted Average) is $10.6 million (2024), against an average of $18.7 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 2678.82% in 2025 and jumped 39.4% in 2026, its largest moves.
• MBX Biosciences' Shares Outstanding (Weighted Average) stood at $1.0 million in 2023, then soared by 944.7% to $10.6 million in 2024, then jumped by 243.01% to $36.5 million in 2025, then advanced by 27.58% to $46.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $46.6 million (Q1 2026), $36.5 million (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.